Opinion|Articles|December 15, 2023
Supplements and Featured Publications
- Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Advertisement
This AJMC® Clinical Brief focuses on managed care considerations for the treatment of spinal muscular atrophy.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
2
Future Directions and Unmet Needs in HER2+ Breast Cancer Therapy
3
Additional Emerging HER2-Targeted Therapies in NSCLC
4
Opportunities for Positioning TKIs as First-Line Therapy in HER2-Mutant NSCLC
5
